Scholars@Duke

Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations

Conferences
Ark, J; Nyberg, W; Havlik, P; To, A; Eyquem, J; Asokan, A
Published in: MOLECULAR THERAPY
April 27, 2021
Link to item

Duke Scholars

Aravind Asokan
Author Aravind Asokan Surgery, Surgical Sciences
Altmetric Attention Stats
Dimensions Citation Stats

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 27, 2021

Volume

29

Issue

4

Start / End Page

32 / 32

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ark, J., Nyberg, W., Havlik, P., To, A., Eyquem, J., & Asokan, A. (2021). Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations. In MOLECULAR THERAPY (Vol. 29, pp. 32–32).
Ark, Jonathan, William Nyberg, Patrick Havlik, Angela To, Justin Eyquem, and Aravind Asokan. “Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations.” In MOLECULAR THERAPY, 29:32–32, 2021.
Ark J, Nyberg W, Havlik P, To A, Eyquem J, Asokan A. Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations. In: MOLECULAR THERAPY. 2021. p. 32–32.
Ark, Jonathan, et al. “Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations.” MOLECULAR THERAPY, vol. 29, no. 4, 2021, pp. 32–32.
Ark J, Nyberg W, Havlik P, To A, Eyquem J, Asokan A. Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations. MOLECULAR THERAPY. 2021. p. 32–32.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 27, 2021

Volume

29

Issue

4

Start / End Page

32 / 32

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics